Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

In a memo to Dr Jones, Dr Rejman stated that the ACVSB had decided that at present NANB was not to be routinely screened for.

  • Read more about In a memo to Dr Jones, Dr Rejman stated that the ACVSB had decided that at present NANB was not to be routinely screened for.

In a letter to Professor Cash, Dr McIntyre stated that the ACVSB was considering the tests available and if it were thought to be desirable to introduce further routine screening, which would be done simultaneously throughout the UK.

  • Read more about In a letter to Professor Cash, Dr McIntyre stated that the ACVSB was considering the tests available and if it were thought to be desirable to introduce further routine screening, which would be done simultaneously throughout the UK.

At a meeting of the ACVSB Dr Gunson presented the preliminary report on the UKBTS study of surrogate and Chiron testing.

  • Read more about At a meeting of the ACVSB Dr Gunson presented the preliminary report on the UKBTS study of surrogate and Chiron testing.

In Dr Rejman's letter to the members of the ACVSB he stated that the Chiron test may also make surrogate testing obsolete, provided that the UKBTS and other studies confirmed the promising results so far reported, and assuming that the cost benefit analysis was satisfactory.

  • Read more about In Dr Rejman's letter to the members of the ACVSB he stated that the Chiron test may also make surrogate testing obsolete, provided that the UKBTS and other studies confirmed the promising results so far reported, and assuming that the cost benefit analysis was satisfactory.

Dr Andrzej Rejman and John Canavan wrote to all members of the ACVSB enclosing a paper from Dr Philip Mortimer titled "Non-A, Non-B Hepatitis".

  • Read more about Dr Andrzej Rejman and John Canavan wrote to all members of the ACVSB enclosing a paper from Dr Philip Mortimer titled "Non-A, Non-B Hepatitis".

Professor Jean-Pierre Allain in a letter to Dr Gunson, Dr McClelland and all RTC directors in England and Wales proposed that they could take advantage of the two months before the implementation of HCV screening to carry out a study testing for anti-HCV in samples from recipients of blood transfusions.

  • Read more about Professor Jean-Pierre Allain in a letter to Dr Gunson, Dr McClelland and all RTC directors in England and Wales proposed that they could take advantage of the two months before the implementation of HCV screening to carry out a study testing for anti-HCV in samples from recipients of blood transfusions.

At a meeting of the ACTTD it was agreed that confirmatory testing should be carried out using the RIBA-2 test. The committee debated the use of PCR tests but concluded that more information was needed.

  • Read more about At a meeting of the ACTTD it was agreed that confirmatory testing should be carried out using the RIBA-2 test. The committee debated the use of PCR tests but concluded that more information was needed.

Dr P Mortimer in a letter to Dr Gunson stated that he still had several concerns about the operation of HCV screening and that it must be decided in the light of the performance of the best screening and confirmatory tests available, and these were to be considered at the next advisory committee meeting.

  • Read more about Dr P Mortimer in a letter to Dr Gunson stated that he still had several concerns about the operation of HCV screening and that it must be decided in the light of the performance of the best screening and confirmatory tests available, and these were to be considered at the next advisory committee meeting.

Dr Gunson reported the outcome of the ACVSB meeting stating that the Department of Health committee had deferred the decision to introduce routine screening and that it was hoped that by their next meeting at the end of April 1990 they would have received further advice and reached a decision.

  • Read more about Dr Gunson reported the outcome of the ACVSB meeting stating that the Department of Health committee had deferred the decision to introduce routine screening and that it was hoped that by their next meeting at the end of April 1990 they would have received further advice and reached a decision.

The ACTTD decided that Dr Gunson's paper should be used as the basis of the paper to be submitted to the department's committee and matters referred to ie counselling and flow charts would form part of the policy decisions to be taken if the Department of Health accepted the recommendation of the Committee.

  • Read more about The ACTTD decided that Dr Gunson's paper should be used as the basis of the paper to be submitted to the department's committee and matters referred to ie counselling and flow charts would form part of the policy decisions to be taken if the Department of Health accepted the recommendation of the Committee.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 254
  • Page 255
  • Page 256
  • Page 257
  • Current page 258
  • Page 259
  • Page 260
  • Page 261
  • Page 262
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.